AbbVie named its chief executive, Robert Michael, to succeed Richard Gonzalez as chairman of the biopharmaceutical company, effective July 1. AbbVie on Friday said Gonzalez, who has been chairman ...

AbbVie made a change atop its board of directors, naming CEO Robert Michael as chairman on Friday morning. The pharma giant announced that Michael will succeed Richard A. Gonzalez, the former CEO of ...

Former AbbVie CEO Richard Gonzalez sold his Hidden Hills home for $21.7 million in the pharma executive’s latest real estate move this year. The closing had been expected after the six-bed, 10 ...

AbbVie Inc. (NYSE:ABBV – Get Free Report) Chairman Richard A. Gonzalez sold 66,500 shares of the stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average ...

According to the latest filings, Gonzalez has sold 66,500 shares of AbbVie's common stock at a weighted average price of $186.52, totaling approximately $12.4 million.

AbbVie Inc . (NYSE:ABBV) Executive Chairman of the Board, Richard A. Gonzalez, has recently sold a significant number of shares in the company. According to the latest filings, Gonzalez has sold ...

Over the past year, Richard Gonzalez has sold a total of 487,961 shares and has not purchased any shares. This recent transaction continues a trend seen within the company, where there have been 13 ...

AbbVie CEO Richard Gonzalez is the latest heavy hitter to buy in Boca Raton. The pharma boss dropped $14.3 million on a waterfront mansion, following a string of eight-figure deals in the city.

In his final full year as AbbVie’s CEO, Richard Gonzalez made $25.7M, which was a slight decline from his $26.3M pay in 2022.

In his last full year as AbbVie CEO, Richard Gonzalez saw his 2023 paycheck shrink slightly amid declining revenues as the pharmaceutical giant's best-selling drug Humira faced biosimilar ...

This week’s news that AbbVie CEO Richard Gonzalez will retire in July after 11 years at the helm is essentially him declaring victory. Despite the U.S. patent cliff for its blockbuster ...

During Gonzalez's decade as CEO, AbbVie nearly tripled its sales revenue. The company grew from $18.8 billion in 2013 to $54.32 billion last year, mostly on the back of its blockbuster arthritis ...